Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROXYCHLOROQUINE DIPHOSPHATE for Covid-19: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where HYDROXYCHLOROQUINE DIPHOSPHATE was used for Covid-19.

Most Reported Side Effects for HYDROXYCHLOROQUINE DIPHOSPHATE

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,220 65.2% 63 253
Rheumatoid arthritis 914 48.9% 69 212
Pain 633 33.9% 69 189
Drug intolerance 607 32.5% 62 184
Joint swelling 559 29.9% 69 175
Fatigue 523 28.0% 65 187
Arthralgia 487 26.0% 62 157
Contraindicated product administered 463 24.8% 56 153
Abdominal discomfort 456 24.4% 63 152
Off label use 441 23.6% 72 176
Treatment failure 421 22.5% 50 129
Arthropathy 409 21.9% 66 175
Alopecia 398 21.3% 62 121
Swelling 386 20.6% 61 114
Condition aggravated 384 20.5% 63 125

Other Indications for HYDROXYCHLOROQUINE DIPHOSPHATE

Rheumatoid arthritis (939) Product used for unknown indication (709) Systemic lupus erythematosus (57) Coronavirus infection (26) Polyarthritis (9) Sjogren's syndrome (8) Lupus nephritis (6) Joint stiffness (5) Mobility decreased (5) Pain (5)

Other Drugs Used for Covid-19

REMDESIVIR (7,196) HYDROXYCHLOROQUINE (5,280) BAMLANIVIMAB (4,621) NIRMATRELVIR\RITONAVIR (4,587) TOCILIZUMAB (4,186) DEXAMETHASONE (2,975) CASIRIVIMAB\IMDEVIMAB (2,943) SOTROVIMAB (2,732) AZITHROMYCIN ANHYDROUS (2,510) METHYLPREDNISOLONE (1,633)

Related Pages

HYDROXYCHLOROQUINE DIPHOSPHATE Full Profile All Covid-19 Drugs HYDROXYCHLOROQUINE DIPHOSPHATE Demographics HYDROXYCHLOROQUINE DIPHOSPHATE Timeline